TMSH (TransGlobal Assets) Market Cap: $0.34 Mil (As of Jun. 25, 2026)


What is TransGlobal Assets Market Cap?

TransGlobal Assets TMSH Market Cap is $0.34 Mil as of Jun. 25, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TransGlobal Assets's share price for the quarter that ended in Dec. 2011 was $0.0065. TransGlobal Assets's Shares Outstanding (EOP) for the quarter that ended in Dec. 2011 was 102.59 Mil. Therefore, TransGlobal Assets's market cap for the quarter that ended in Dec. 2011 was $0.67 Mil.

TransGlobal Assets's quarterly market cap increased from Dec. 2009 ($0.94 Mil) to Dec. 2010 ($52.73 Mil) but then declined from Dec. 2010 ($52.73 Mil) to Dec. 2011 ($0.67 Mil).

TransGlobal Assets's annual market cap increased from Dec. 2009 ($0.94 Mil) to Dec. 2010 ($52.73 Mil) but then declined from Dec. 2010 ($52.73 Mil) to Dec. 2011 ($0.67 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TransGlobal Assets's Enterprise Value for Today is $0.34 Mil.


TransGlobal Assets  (OTCPK:TMSH) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


TransGlobal Assets Market Cap Related Terms


TransGlobal Assets Market Cap Historical Data

* Premium members only.

The historical data trend for TransGlobal Assets's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TransGlobal Assets Market Cap Chart

TransGlobal Assets Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Market Cap
0.00 0.15 0.94 52.73 0.67

TransGlobal Assets Semi-Annual Data
Dec07 Dec08 Dec09 Dec10 Dec11
Market Cap 0.00 0.15 0.94 52.73 0.67

TMSH vs CLDOF: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TransGlobal Assets's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TransGlobal Assets Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TransGlobal Assets's Market Cap distribution charts can be found below:

* The bar in red indicates where TransGlobal Assets's Market Cap falls into.



TransGlobal Assets Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

TransGlobal Assets's Market Cap for the fiscal year that ended in Dec. 2011 is calculated as

Market Cap (A: Dec. 2011 )=Share Price (A: Dec. 2011 )*Shares Outstanding (EOP) (A: Dec. 2011 )
=$0.0065*102.587
=$0.67

TransGlobal Assets's Market Cap for the quarter that ended in Dec. 2011 is calculated as

Market Cap (Q: Dec. 2011 )=Share Price (Q: Dec. 2011 )*Shares Outstanding (EOP) (Q: Dec. 2011 )
=$0.0065*102.587
=$0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.34 Mil mean?
TransGlobal Assets (TMSH) has a Market Cap of $0.34 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TransGlobal Assets and its competitors.
Is TransGlobal Assets' Market Cap too high?
TransGlobal Assets' current Market Cap is $0.34 Mil. The Drug Manufacturers industry median Market Cap is 206.50. TransGlobal Assets' value of $0.34 Mil is 99.8% below this industry median.
How does TransGlobal Assets' Market Cap compare to CLDOF?
TransGlobal Assets' Market Cap of $0.34 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 206.50. TransGlobal Assets' value of $0.34 Mil is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.50, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TransGlobal Assets's current Market Cap of $0.34 Mil is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TransGlobal Assets and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransGlobal Assets's current Market Cap is $0.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransGlobal Assets stock overvalued right now?
TransGlobal Assets (TMSH) has a current Market Cap of $0.34 Mil. The current Market Cap is $0.34 Mil and 99.8% below the Drug Manufacturers industry median of 206.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For TransGlobal Assets (TMSH), the current Market Cap is $0.34 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TransGlobal Assets Business Description

Address No. 14, 5555 Sagamore Avenue, Portsmouth, NH, USA, 03801
TransGlobal Assets Inc through its subsidiary Mindwell Solutions Group LLC (MWSG), the company develops proprietary solutions that harness AI, biometric analysis, and behavioral data to address high-growth markets, including mental health, relationship wellness, performance analytics, and sports/entertainment. and also offers a pioneer in transforming the health and wellness industries through cutting-edge products and services. The products and services are focused on being at the forefront of the health and wellness sectors, developing technologies and solutions that are driving industry growth and transforming lives. The portfolio includes a range- of-products and services, from telemedicine platforms to wellness retreats and natural health remedies.